Publication | Open Access
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
381
Citations
22
References
2021
Year
ClinicalTrials.gov Identifier: NCT03594747.
| Year | Citations | |
|---|---|---|
Page 1
Page 1